Search Results - "Ilson, DH"

Targeted Therapies for Esophageal Cancer by Tew, William P., Kelsen, David P., Ilson, David H.

“…Learning Objectives After completing this course, the reader will be able to: Discuss the epidemiology of esophageal cancer. Explain the current status of…”
Get full text

Oesophageal cancer: new developments in systemic therapy by Ilson, David H

“…Oesophageal cancer is a rare but highly virulent malignancy in the United States and Western countries, and adenocarcinoma of the oesophagus has had the most…”
Get full text

Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer by Ilson, DH, Wadleigh, RG, Leichman, LP, Kelsen, DP

“…Background: The purpose of the study was to evaluate the efficacy of weekly paclitaxel (Taxol) in advanced esophageal cancer. Patients and methods: One hundred…”
Get full text

Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma by Kawakami, Kazuyuki, Brabender, Jan, Lord, Reginald V., Groshen, Susan, Greenwald, Bruce D., Krasna, Mark J., Yin, Jing, Fleisher, A. Steven, Abraham, John M., Beer, David G., Sidransky, David, Huss, Harold T., Demeester, Tom R., Eads, Cindy, Laird, Peter W., Ilson, David H., Kelsen, David P., Harpole, David, Moore, Mary-Beth, Danenberg, Kathleen D., Danenberg, Peter V., Meltzer, Stephen J.

“…Background: The adenomatous polyposis coli (APC) locus on chromosome 5q21–22 shows frequent loss of heterozygosity (LOH) in esophageal carcinomas. However, the…”
Get full text

Phase II Trial of Weekly Irinotecan Plus Cisplatin in Advanced Esophageal Cancer by ILSON, D. H, SALTZ, L, KELSEN, D. P, ENZINGER, P, YING HUANG, KORNBLITH, A, GOLLUB, M, O'REILLY, E, SCHWARTZ, G, DEGROFF, J, GONZALEZ, G

“…To evaluate the response, toxicity, survival, and quality of life in patients with unresectable or metastatic esophageal cancer treated with weekly irinotecan…”
Get full text

Phase I Trial of Escalating-Dose Irinotecan Given Weekly With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Cancer by ILSON, David H, BAINS, Manjit, KELSEN, David P, O'REILLY, Eileen, KARPEH, Martin, COIT, Daniel, RUSCH, Valerie, GONEN, Mithat, WILSON, Katie, MINSKY, Bruce D

“…To identify the maximum-tolerated dose and dose-limiting toxicity (DLT) of weekly irinotecan combined with cisplatin and radiation in esophageal cancer…”
Get full text

Treatment of localized esophageal cancer by Brenner, Baruch, Ilson, David H., Minsky, Bruce D.

“…The treatment of localized esophageal cancer (LEC) is controversial. The approaches that are used in daily practice include surgery or radiation alone,…”
Get full text

Phase I Trial of Combined-Modality Therapy for Localized Esophageal Cancer: Escalating Doses of Continuous-Infusion Paclitaxel With Cisplatin and Concurrent Radiation Therapy by BRENNER, Baruch, ILSON, David H, MINSKY, Bruce D, BAINS, Manjit S, TONG, William, GONEN, Mithat, KELSEN, David P

“…To define the maximum-tolerated dose (MTD) of paclitaxel when given as a weekly 96-hour infusion with cisplatin and radiotherapy for patients with esophageal…”
Get full text

Chemotherapy in esophageal cancer by Enzinger, P C, Ilson, D H, Kelsen, D P

“…The incidence of esophageal cancer continues to increase due to a rapid increase in adenocarcinoma of the distal esophagus and gastroesophageal junction. At…”
Get more information

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus by Ilson, D H, Ajani, J, Bhalla, K, Forastiere, A, Huang, Y, Patel, P, Martin, L, Donegan, J, Pazdur, R, Reed, C, Kelsen, D P

“…We have previously identified paclitaxel as an active single agent in the treatment of esophageal cancer. We performed a phase II trial of paclitaxel in…”
Get more information

A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: Initial results by Bains, Manjit S., Stojadinovic, Alexander, Minsky, Bruce, Rusch, Valerie, Turnbull, Alan, Korst, Robert, Ginsberg, Robert, Kelsen, David P., Ilson, David H.

“…Objective: We sought to evaluate treatment response to a novel combined-modality treatment regimen for localized esophageal carcinoma. Methods: Localized…”
Get full text

Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead? by Ilson, David H

Get full text

A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus by Ilson, D H, Forastiere, A, Arquette, M, Costa, F, Heelan, R, Huang, Y, Kelsen, D P

“…In a phase II trial of paclitaxel, cisplatin, and fluorouracil in metastatic esophageal cancer, we identified significant activity for the combination of…”
Get more information

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus by Ajani, J A, Ilson, D H, Daugherty, K, Pazdur, R, Lynch, P M, Kelsen, D P

“…Carcinomas of the esophagus and gastroesophageal junction are uncommon and account for approximately 1% of all malignancies in the United States. Advanced…”
Get more information

Editorial on a Phase I Study on Combined Modality Therapy in Esophageal Cancer by Ilson, David

Get full text

Cytogenetic analysis of 124 prospectively ascertained male germ cell tumours by RODRIGUEZ, E, MATHEW, S, REUTER, V, ILSON, D. H, BOSL, G. J, CHAGANTI, R. S. K

“…We report the cytogenetic analysis of 124 adult male germ cell tumors ascertained consecutively at the Memorial Sloan-Kettering Cancer Center between 1988 and…”
Get full text

Phase II Trial of 96-Hour Paclitaxel in Previously Treated Patients with Advanced Esophageal Cancer by Anderson, Sibyl E., O'Reilly, Eileen M., Kelsen, David P., Ilson, David H.

“…Background. A 96-hour infusion schedule of paclitaxel demonstrates tolerability and antitumor activity in lung cancer and breast cancer refractory to…”
Get full text

Irinotecan, cisplatin, and radiation in esophageal cancer by Ilson, David H, Minsky, Bruce, Kelsen, David

“…The limited effectiveness of currently available chemotherapy in the treatment of advanced esophageal cancer, and the poor survival achieved in locally…”
Get more information

Adjuvant therapy for noncolorectal cancers by Ilson, David H

“…Cancers of the esophagus, stomach, and pancreas account for 11% of American cancer deaths and have a high case fatality rate. For esophageal cancer, the…”
Get full text

Combined modality therapy in the treatment of esophageal cancer by Ilson, D H, Kelsen, D P

Get more information